← Leaderboards
Ani Wang Manichaikul
University Of Virginia
$5,817,057
Attributed
$10,229,505
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2016–25$5M$3.8M$2.5M$1.3M$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,229,505 · 6
By mechanism
R01$10,229,505 · 6
Top collaborators
- Michael H. Cho5 shared
- Yun Michael Shim5 shared
- Dajiang Liu2 shared
- Matthew R Taylor2 shared
- Hae Kyung Im1 shared
Most similar at University Of Virginia
Same institution · by research overlap
- Yun Michael Shim$6,424,060
- Brent A French$10,427,669
- Xudong Joshua Li$4,493,519
- Kevin R Lynch$18,485,029
- Webster L Santos$7,267,557
Others in their field
Top investigators on “Genes”
- David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
- Richard A Gibbs · Baylor College Of Medicine$338,750,128
- Barton F Haynes · Duke University$304,076,400
- Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
- Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
- Richard K. Wilson · Washington University$195,881,965
Research focus
GenesTissuesPathogenesisStructure Of Parenchyma Of LungTranscriptomicsTranscriptome SequencingGenomicsGeneticVariantLungPathway InteractionsData SetGenome Wide Association StudyAffectUnited StatesDiagnosisTranscriptomeGene ExpressionCause Of DeathParticipantBiologicalCohortEtiologyMortality
Grant awards (17)
Interrogating the pathogenesis of COPD using metabolomics and genomics data$800,679
R01 · FY2025 · HL · contact PI
Sexual dimorphism in susceptibility to emphysematous tissue injury$728,054
R01 · FY2025 · HL
Integrative genomic and transcriptomic investigation of human heart failure mechanisms$631,780
R01 · FY2025 · HL
Multi-omic Characterization of COPD in Females$552,040
R01 · FY2025 · HL
Sexual dimorphism in susceptibility to emphysematous tissue injury$715,914
R01 · FY2024 · HL
Integrative genomic and transcriptomic investigation of human heart failure mechanisms$624,142
R01 · FY2024 · HL
Integrative genomic, transcriptomic and proteomic studies of pulmonary function and COPD$606,652
R01 · FY2024 · HL · contact PI
Multi-omic Characterization of COPD in Females$572,076
R01 · FY2024 · HL
Sexual dimorphism in susceptibility to emphysematous tissue injury$773,943
R01 · FY2023 · HL
Integrative genomic, transcriptomic and proteomic studies of pulmonary function and COPD$650,695
R01 · FY2023 · HL · contact PI
Integrative genomic, transcriptomic and proteomic studies of pulmonary function and COPD$758,323
R01 · FY2022 · HL · contact PI
Integrative genomic, transcriptomic and proteomic studies of pulmonary function and COPD$768,999
R01 · FY2021 · HL · contact PI
Genomic and Transcriptomic Analysis of Emphysema and Subclinical ILD$400,630
R01 · FY2020 · HL · contact PI
Genomic and Transcriptomic Analysis of Emphysema and Subclinical ILD$400,585
R01 · FY2019 · HL · contact PI
Genomic and Transcriptomic Analysis of Emphysema and Subclinical ILD$400,540
R01 · FY2018 · HL · contact PI
Genomic and Transcriptomic Analysis of Emphysema and Subclinical ILD$400,498
R01 · FY2017 · HL · contact PI
Genomic and Transcriptomic Analysis of Emphysema and Subclinical ILD$443,955
R01 · FY2016 · HL · contact PI